세계의 바르토넬라증 시장 보고서(2025년)

Bartonellosis Global Market Report 2025

US $ 4,490 ￦ 6,342,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,167,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 11,992,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

바르토넬라증 시장 규모는 향후 수년간 급성장이 전망될 예정입니다. 예측 기간의 성장은 맞춤형 의료에 대한 주목의 높아짐, 고양이 스크래치 질환에 대한 의식 증가 등에 기인한다고 생각됩니다. 이 기간에 예상되는 주요 동향에는 의료 기술과 바이오 테크놀로지의 진보, 복합 검사법의 개발, 진단 기술의 향상, 계속적인 연구 개발 노력이 포함됩니다.

인간 짐승 공통 감염의 유행 증가가 향후 몇 년간의 바르토넬라증 시장의 성장을 견인할 것으로 예측됩니다. 환경의 변화, 삼림 벌채, 세계의 여행, 병원체의 종을 넘은 확산 등의 요인에 기인하고 있습니다. 임상 증상을 일으키는 세균성 병원체의 중요한 예입니다. 이것은 공중 보건에서 매개 감염의 전파를 이해하는 것의 중요성을 강조합니다. 예를 들어, 2023년 1월 연방 정부 기관인 캐나다 정부가 발표한 보고서에 따르면 2022년 10월에 135개의 광견병 샘플이 제출된 데 비해 2022년 11월에는 159개의 광견병 샘플이 제출되었다고 합니다.

바르토넬라증 시장의 주요 기업은 이 질병의 조기 발견과 치료법 개선을 위한 자금 조달 활동을 우선하고 있습니다. 이를 통해 혁신이 촉진되고 건강 관리 솔루션에 대한 액세스가 향상됩니다. 예를 들어, 2022년 4월 미국의 비영리 단체인 글로벌 라임 얼라이언스(GLA)는 신경 염증 및 정신 질환과 같은 심각한 건강 상태와 관련된 숨겨진 병원균인 바르토넬라균에 대한 선구적인 연구를 위해 30만 달러를 모금하는 크라우드 펀딩 캠페인을 시작했습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계의 바르토넬라증 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인과 억제요인)
• 최종 이용 산업의 분석
• 세계의 바르토넬라증 시장 : 성장률 분석
• 세계의 바르토넬라증 시장 실적 : 규모와 성장(2019-2024년)
• 세계의 바르토넬라증 시장 예측 : 규모와 성장(2024-2029년, 2034년)
• 세계의 바르토넬라증 전체 시장(TAM)

제6장 시장 세분화

• 세계의 바르토넬라증 시장 : 질환 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 고양이 스크래치 질환(CSD)
• 트렌치열
• 바르토넬라 심내막염
• 기타 질병 유형
• 세계의 바르토넬라증 시장 : 진단 방법별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 중합효소 연쇄반응(PCR) 검사
• 혈청학적 검사
• 배양 방법
• 조직학적 검사
• 세계의 바르토넬라증 시장 : 치료별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 항생제
• 항균제
• 지지 치료
• 세계의 바르토넬라증 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 병원 및 진료소
• 진단실험실
• 기타 최종 사용자
• 세계의 바르토넬라증 시장 : 고양이 스크래치 질환(CSD) 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 면역력이 없는 숙주
• 면역력이 약한 숙주
• 신경학적 합병증
• 세계의 바르토넬라증 시장 : 트렌치열 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 급성 트렌치열
• 만성 트렌치열
• 무증상 감염
• 세계의 바르토넬라증 시장 : 바르토넬라 심내막염 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 자연 판막 심내막염
• 인공 판막 심내막염
• 혈류 감염
• 세계의 바르토넬라증 시장 : 기타 질병 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 세균성 혈관종양증
• 파리노 안선 증후군
• 바르토넬라 관련 혈관염

제7장 지역별/국가별 분석

• 세계의 바르토넬라증 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 세계의 바르토넬라증 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

• 바르토넬라증 시장 : 경쟁 구도
• 바르토넬라증 시장 : 기업 프로파일
  • Mayo Clinic Laboratories 개요, 제품 및 서비스, 전략 및 재무 분석
  • Northwell Health Labs 개요, 제품 및 서비스, 전략 및 재무 분석
  • Laboratory Corporation of America Holdings 개요, 제품 및 서비스, 전략 및 재무 분석
  • Quest Diagnostics Incorporated 개요, 제품 및 서비스, 전략 및 재무 분석
  • IDEXX Laboratories Inc. 개요, 제품 및 서비스, 전략 및 재무 분석

제31장 기타 주요 기업 및 혁신 기업

• Bio-Rad Laboratories Inc.
• Alberta Precision Laboratories
• Jiangsu BioPerfectus Technologies Co. Ltd.
• ARUP Laboratories
• Surmodics Inc.
• Medical Diagnostic Laboratories LLC
• Creative Biolabs
• IGeneX Inc.
• Karius Inc.
• Synnovis Group LLP
• Galaxy Diagnostics Inc.
• Gold Standard Diagnostics
• Eurofins Biomnis
• AMMAGENOMICS Private Limited
• Ringbio

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

• 바르토넬라증 시장(2029년) : 새로운 기회를 제공하는 국가
• 바르토넬라증 시장(2029년) : 새로운 기회를 제공하는 부문
• 바르토넬라증 시장(2029년) : 성장 전략
  • 시장 동향에 기초한 전략
  • 경쟁 전략

제36장 부록

KTH

영문 목차

영문목차

Bartonellosis is a bacterial infection caused by the Bartonella genus, affecting the skin, lymph nodes, and internal organs. Prompt diagnosis and antibiotic treatment are crucial to prevent severe systemic complications and ensure effective disease management.

The primary forms of bartonellosis include cat scratch disease (CSD), trench fever, Bartonella endocarditis, and others. Cat scratch disease, caused by Bartonella henselae and transmitted through cat scratches or bites, results in symptoms such as swollen lymph nodes, fever, and fatigue. Diagnosis involves various methods, including polymerase chain reaction (PCR) testing, serological testing, culture techniques, and histological examination. Treatment options consist of antibiotics, antibacterial agents, and supportive care. The disease is managed by various end-users, including hospitals and clinics, diagnostic laboratories, and others.

The bartonellosis market research report is one of a series of new reports from The Business Research Company that provides bartonellosis market statistics, including the bartonellosis industry global market size, regional shares, competitors with the bartonellosis market share, detailed bartonellosis market segments, market trends, and opportunities, and any further data you may need to thrive in the bartonellosis industry. This bartonellosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The bartonellosis market size has grown rapidly in recent years. It will grow from $1.17 billion in 2024 to $1.31 billion in 2025 at a compound annual growth rate (CAGR) of 12.0%. The growth during the historic period can be attributed to the rising prevalence of Bartonella disease, increased healthcare expenditure, greater funding for research and development, the growing incidence of transmissible illnesses, and the increasing occurrence of infectious diseases.

The bartonellosis market size is expected to see rapid growth in the next few years. It will grow to $2.03 billion in 2029 at a compound annual growth rate (CAGR) of 11.7%. The growth during the forecast period can be attributed to the increasing incidence of zoonotic diseases, rising disease awareness, a growing pet-owning population, a stronger focus on personalized medicine, and greater awareness of cat scratch disease. Key trends expected in this period include advancements in medical technology and biotechnology, the development of combined testing methods, improvements in diagnostic techniques, and continuous research and development efforts.

The increasing prevalence of zoonotic diseases is anticipated to drive the growth of the bartonellosis market in the coming years. Zoonotic diseases are infections transmitted from animals to humans, either directly or via vectors. The surge in zoonotic disease cases can be attributed to factors such as heightened human-animal interactions, environmental changes, deforestation, global travel, and the cross-species spread of pathogens. Bartonellosis serves as a significant example of a bacterial pathogen transmitted through animal vectors such as fleas, ticks, and lice, which can infect humans and cause various clinical manifestations. This underscores the importance of understanding vector-borne disease transmission in public health. For instance, in January 2023, a report published by the Government of Canada, a federal authority, indicated that 159 rabies samples were submitted in November 2022, compared to 135 samples in October 2022. Consequently, the growing incidence of zoonotic diseases is fueling the expansion of the bartonellosis market.

Leading companies in the bartonellosis market are prioritizing fundraising initiatives to enhance early detection and improve treatment options for the disease. These efforts involve organizations raising funds to support research, diagnosis, treatment, and prevention of bartonellosis, thereby fostering innovation and improving access to healthcare solutions. For example, in April 2022, the Global Lyme Alliance (GLA), a US-based nonprofit organization, launched a crowdfunding campaign to raise $300,000 for pioneering research on Bartonella, a hidden pathogen linked to severe health conditions such as neuroinflammation and psychiatric disorders. This initiative coincided with Lyme Disease Awareness Month and aimed to deepen the understanding of Bartonella's behavior within the body, which is essential for developing more effective treatments for Bartonella infections and related conditions such as Lyme disease. The campaign highlighted the need for greater awareness and funding to assist individuals affected by these debilitating diseases.

In October 2024, R.E.D. Laboratories, a Belgium-based biomedical diagnostic company, collaborated with IGeneX Inc. to broaden access to IGeneX's advanced testing panels. Through this partnership, customers in Europe, Africa, and the Middle East can directly access IGeneX's specialized Lyme disease and co-infection tests via RED Labs. IGeneX Inc. is a US-based provider of diagnostic test kits for bartonellosis.

Major players in the bartonellosis market are Mayo Clinic Laboratories, Northwell Health Labs, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, IDEXX Laboratories Inc., Bio-Rad Laboratories Inc., Alberta Precision Laboratories, Jiangsu BioPerfectus Technologies Co. Ltd., ARUP Laboratories, Surmodics Inc., Medical Diagnostic Laboratories LLC, Creative Biolabs, IGeneX Inc., Karius Inc., Synnovis Group LLP, Galaxy Diagnostics Inc., Gold Standard Diagnostics, Eurofins Biomnis, AMMAGENOMICS Private Limited, Ringbio.

North America was the largest region in the bartonellosis market in 2024. The regions covered in bartonellosis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the bartonellosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The bartonellosis market consists of revenues earned by entities by providing services such as medical consultation, symptom management, and vector control and prevention. The market value includes the value of related goods sold by the service provider or included within the service offering. The bartonellosis market includes sales of diagnostic kits, preventive products, pain relievers, and immune support supplements. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bartonellosis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on bartonellosis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for bartonellosis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The bartonellosis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Disease Type: Cat Scratch Disease (CSD); Trench Fever; Bartonella Endocarditis; Other Disease Types
• 2) By Diagnostic Method: Polymerase Chain Reaction (PCR) Testing; Serological Testing; Culture Methods; Histological Testing
• 3) By Treatment: Antibiotics; Antibacterial Agents; Supportive Care
• 4) By End-User: Hospitals And Clinics; Diagnostic Laboratories; Other End-Users
• Subsegments:
• 1) By Cat Scratch Disease (CSD): Immunocompetent Hosts; Immunocompromised Hosts; Neurological Complications
• 2) By Trench Fever: Acute Trench Fever; Chronic Trench Fever; Asymptomatic Infections
• 3) By Bartonella Endocarditis: Native Valve Endocarditis; Prosthetic Valve Endocarditis; Bloodstream Infections
• 4) By Other Disease Types: Bacillary Angiomatosis; Parinaud's Oculoglandular Syndrome; Bartonella-associated Vasculitis
• Companies Mentioned: Mayo Clinic Laboratories; Northwell Health Labs; Laboratory Corporation of America Holdings; Quest Diagnostics Incorporated; IDEXX Laboratories Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Bartonellosis Market Characteristics

3. Bartonellosis Market Trends And Strategies

4. Bartonellosis Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Bartonellosis Growth Analysis And Strategic Analysis Framework

• 5.1. Global Bartonellosis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Bartonellosis Market Growth Rate Analysis
• 5.4. Global Bartonellosis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Bartonellosis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Bartonellosis Total Addressable Market (TAM)

6. Bartonellosis Market Segmentation

• 6.1. Global Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cat Scratch Disease (CSD)
• Trench Fever
• Bartonella Endocarditis
• Other Disease Types
• 6.2. Global Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Polymerase Chain Reaction (PCR) Testing
• Serological Testing
• Culture Methods
• Histological Testing
• 6.3. Global Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antibiotics
• Antibacterial Agents
• Supportive Care
• 6.4. Global Bartonellosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Diagnostic Laboratories
• Other End-Users
• 6.5. Global Bartonellosis Market, Sub-Segmentation Of Cat Scratch Disease (CSD), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immunocompetent Hosts
• Immunocompromised Hosts
• Neurological Complications
• 6.6. Global Bartonellosis Market, Sub-Segmentation Of Trench Fever, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Acute Trench Fever
• Chronic Trench Fever
• Asymptomatic Infections
• 6.7. Global Bartonellosis Market, Sub-Segmentation Of Bartonella Endocarditis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Native Valve Endocarditis
• Prosthetic Valve Endocarditis
• Bloodstream Infections
• 6.8. Global Bartonellosis Market, Sub-Segmentation Of Other Disease Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bacillary Angiomatosis
• Parinaud's Oculoglandular Syndrome
• Bartonella-associated Vasculitis

7. Bartonellosis Market Regional And Country Analysis

• 7.1. Global Bartonellosis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Bartonellosis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Bartonellosis Market

• 8.1. Asia-Pacific Bartonellosis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Bartonellosis Market

• 9.1. China Bartonellosis Market Overview
• 9.2. China Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Bartonellosis Market

• 10.1. India Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Bartonellosis Market

• 11.1. Japan Bartonellosis Market Overview
• 11.2. Japan Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Bartonellosis Market

• 12.1. Australia Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Bartonellosis Market

• 13.1. Indonesia Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Bartonellosis Market

• 14.1. South Korea Bartonellosis Market Overview
• 14.2. South Korea Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Bartonellosis Market

• 15.1. Western Europe Bartonellosis Market Overview
• 15.2. Western Europe Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Bartonellosis Market

• 16.1. UK Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Bartonellosis Market

• 17.1. Germany Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Bartonellosis Market

• 18.1. France Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Bartonellosis Market

• 19.1. Italy Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Bartonellosis Market

• 20.1. Spain Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Bartonellosis Market

• 21.1. Eastern Europe Bartonellosis Market Overview
• 21.2. Eastern Europe Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Bartonellosis Market

• 22.1. Russia Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Bartonellosis Market

• 23.1. North America Bartonellosis Market Overview
• 23.2. North America Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Bartonellosis Market

• 24.1. USA Bartonellosis Market Overview
• 24.2. USA Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Bartonellosis Market

• 25.1. Canada Bartonellosis Market Overview
• 25.2. Canada Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Bartonellosis Market

• 26.1. South America Bartonellosis Market Overview
• 26.2. South America Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Bartonellosis Market

• 27.1. Brazil Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Bartonellosis Market

• 28.1. Middle East Bartonellosis Market Overview
• 28.2. Middle East Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Bartonellosis Market

• 29.1. Africa Bartonellosis Market Overview
• 29.2. Africa Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Bartonellosis Market Competitive Landscape And Company Profiles

• 30.1. Bartonellosis Market Competitive Landscape
• 30.2. Bartonellosis Market Company Profiles
  • 30.2.1. Mayo Clinic Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Northwell Health Labs Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. IDEXX Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Bartonellosis Market Other Major And Innovative Companies

• 31.1. Bio-Rad Laboratories Inc.
• 31.2. Alberta Precision Laboratories
• 31.3. Jiangsu BioPerfectus Technologies Co. Ltd.
• 31.4. ARUP Laboratories
• 31.5. Surmodics Inc.
• 31.6. Medical Diagnostic Laboratories LLC
• 31.7. Creative Biolabs
• 31.8. IGeneX Inc.
• 31.9. Karius Inc.
• 31.10. Synnovis Group LLP
• 31.11. Galaxy Diagnostics Inc.
• 31.12. Gold Standard Diagnostics
• 31.13. Eurofins Biomnis
• 31.14. AMMAGENOMICS Private Limited
• 31.15. Ringbio

32. Global Bartonellosis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Bartonellosis Market

34. Recent Developments In The Bartonellosis Market

35. Bartonellosis Market High Potential Countries, Segments and Strategies

• 35.1 Bartonellosis Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Bartonellosis Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Bartonellosis Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료